Gaurang Shah of Geojit Financial Services told CNBC-TV18, "We do have a coverage on Lupin and unfortunately, our target is Rs 1,650. In case if one wants to average out, it is prudent on my part to advise that because at levels where the stock is trading, Rs 1,135 or thereabouts, it is a good risk reward if you ask me. So I would say average it out. There was some announcement of some uproar coming from US FDA for Lupin."
"Slowly and steadily, resolution for the Indian pharmaceuticals is looking positive, so you should bet on companies which have got capabilities and capacities of getting these resolution in place. Lupin happens to be one of those companies which we believe will be a good long-term bet."
"Tata Motors is one of the greatest underperformer if you purely compare it with Mahindra and Mahindra (M&M) or Maruti Suzuki. This is short to medium term; in long term, we remain extremely positive and yes there has been turnaround. JLR numbers globally has come out good, better than expected. Our sense is that the light commercial vehicle (LCV), medium heavy commercial vehicles (MHCV) traction is going to improve, defence related supply is going to throw in positivity and the domestic business is going to throw in positivity in terms of new launches. So, convert your horizon into long term, you can make better money in terms of profit margin and return on your investment."
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!